About Neurofenix
Neurofenix is a company based in London (United Kingdom) founded in 2016. Neurofenix has raised $7 million across 2 funding rounds from investors including AlbionVC, Inhealth Ventures and HTH. The company has 13 employees as of December 31, 2023. Neurofenix offers products and services including Virtual Care Program, NeuroPlatform, and NeuroBall. Neurofenix operates in a competitive market with competitors including HyperIce, Neofect, MedRhythms, Noctrix Health and Neurovalens, among others.
- Headquarter London, United Kingdom
- Employees 13 as on 31 Dec, 2023
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurofenix Limited
- Date of Incorporation 23 May, 2016
- Jurisdiction STRATFORD-UPON-AVON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7 M (USD)
in 2 rounds
-
Latest Funding Round
$7 M (USD), Series A
Aug 26, 2022
-
Investors
AlbionVC
& 3 more
-
Employee Count
13
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurofenix
Neurofenix offers a comprehensive portfolio of products and services, including Virtual Care Program, NeuroPlatform, and NeuroBall.
Delivers at-home therapy for neurological rehabilitation.
Tracks patient progress remotely for effective care.
Enables independent hand and arm exercises at home.
People of Neurofenix
Unlock access to complete
Funding Insights of Neurofenix
Neurofenix has successfully raised a total of $7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $7 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neurofenix
Neurofenix has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include AlbionVC, Inhealth Ventures and HTH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on investing in tech startups
|
Locked | Locked | Locked | |
|
Investments are directed by Inhealth Ventures to healthcare companies.
|
Locked | Locked | Locked | |
|
HTH is engaged in investing in health technology startups.
|
Locked | Locked | Locked |
Investor details for Neurofenix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurofenix
Investment portfolio details for Neurofenix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurofenix
Detailed financials for Neurofenix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurofenix Comparisons
Peer comparison for Neurofenix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurofenix
Neurofenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HyperIce, Neofect, MedRhythms, Noctrix Health and Neurovalens, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Internet first brand offering smart devices for physical fitness
|
|
| Locked | Locked | Locked |
Smart rehabilitation devices for neurological injuries are developed by Neofect.
|
|
| Locked | Locked | Locked |
Provider of wearable devices to combat neurological injuries and recover walking functions
|
|
| Locked | Locked | Locked |
Wearable therapeutic devices for neurological disorders are developed.
|
|
| Locked | Locked | Locked |
A headset-like device for obesity treatment is developed by Neurovalens.
|
|
| Locked | Locked | Locked |
Assistive technology is developed for impaired executive brain functions.
|
Detailed competitors of Neurofenix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurofenix
Complete news archive for Neurofenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurofenix
Neurofenix was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Neurofenix is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Neurofenix is a funded company, having raised a total of $7M across 2 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Neurofenix is 13.
Neurofenix was established in 2016 in London, United Kingdom. Operations are centered on the production of medical devices within the neurorehabilitation sector. These devices are designed for integration into muscle-strengthening therapy sessions, supporting patient recovery in healthcare settings. The company maintains its base in the UK, contributing to advancements in rehabilitation technology for clinical applications.
Neurofenix's top competitors include HyperIce, MedRhythms and KT Tape.
Neurofenix offers Virtual Care Program, NeuroPlatform, and NeuroBall.
Neurofenix has 4 investors. Key investors include AlbionVC, Inhealth Ventures, HTH, and o2h ventures.